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Abstract
Background: The association of testicular microlithiasis with testicular tumour and the need for
follow-up remain largely unclear.
Methods: We conducted a national questionnaire survey involving consultant BAUS members
(BAUS is the official national organisation (like the AUA in USA) of the practising urologists in the
UK and Ireland), to provide a snapshot of current attitudes towards investigation and surveillance
of patients with testicular microlithiasis.
Results: Of the 464 questionnaires sent to the BAUS membership, 263(57%) were returned. 251
returns (12 were incomplete) were analysed, of whom 173(69%) do and 78(31%) do not follow-up
testicular microlithiasis. Of the 173 who do follow-up, 119(69%) follow-up all patients while
54(31%) follow-up only a selected group of patients. 172 of 173 use ultra sound scan while 27(16%)
check tumour makers. 10(6%) arrange ultrasound scan every six months, 151(88%) annually while
10(6%) at longer intervals. 66(38%) intend to follow-up these patients for life while, 80(47%) until
55 years of age and 26(15%) for up to 5 years. 173(68.9%) believe testicular microlithiasis is
associated with CIS in < 1%, 53(21%) think it is between 1&10% while 7(3%) believe it is > 10%.
109(43%) believe those patients who develop a tumour, will have survival benefit with follow-up
while 142(57%) do not. Interestingly, 66(38%) who follow-up these patients do not think there is
a survival benefit.
Conclusion:  There is significant variability in how patients with testicular microlithiasis are
followed-up. However a majority of consultant urologists nationally, believe surveillance of this
patient group confers no survival benefit. There is a clear need to clarify this issue in order to
recommend a coherent surveillance policy.
Background
Ever since Doherty et al [1] described testicular microlith-
iasis on ultrasound scan in the late 80 s, the interest in this
subject had been on the increase. However despite an
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association of testicular microlithiasis with testicular
tumour [2-8] its aetiological role and the need for follow-
up have remained largely unclear. The incidence of micro-
lithiasis detection has increased with the development of
more sensitive ultrasound transducers in the recent past
and this has in turn increased patient anxiety in addition
to the NHS workload. The cost of on going radiological
surveillance of this patient group could also be phenome-
nal. A recent prospective follow-up study of patients with
incidentally diagnosed testicular microlithiasis by Ray-
mond A Costabile [9,10], shows no link between inciden-
tally diagnosed testicular microlithiasis on ultrasound
and testicular tumour. However the importance of testic-
ular microlithiasis in patients with a high risk of develop-
ing testicular tumour such as cryptorchidism, small
atrophic testis, sub-fertile men and testicular tumour in
the contra lateral testis is not clear and needs further eval-
uation [12,13]. With conflicting evidence for the rationale
of routinely following patients with incidentally diag-
nosed testicular microlithiasis [9-11] we conducted a
national survey to provide a snapshot of current attitudes
towards investigation and surveillance of this patient
group in the United Kingdom.
Methods
A standardised questionnaire was sent to the 464 consult-
ants on the British Association of Urological Surgeons
(BAUS) register. BAUS is the official national organisation
(like the AUA in USA) of the practising urologists in the
UK and Ireland. The questionnaire aimed to record indi-
vidual consultants' preferred practice for managing
patients in whom a finding of testicular microlithiasis is
made.
Participants were asked initially whether they chose to
routinely follow-up these patients and, if so, how this was
achieved:
• All patients or a selected group only
• Intended duration of follow-up (life-long/up to 55 yrs of
age/<5 yrs)
• Surveillance modality used (Clinical examination/ultra-
sound/tumour markers/Biopsy)
• Frequency of follow-up ultrasonography if utilised
Participants were also asked to record their opinion with
regard to whether they felt a survival advantage was con-
ferred for those who go on to develop a testicular malig-
nancy by surveillance of this microlithiasis group. In
addition, the participants' perceptions of the degree of
association between microlithiasis and testicular carci-
noma-in-situ were also requested.
Results
Of the 464 questionnaires sent out, 263 (57%) were
returned of which 12 were inadequately completed. A
total of 251 were therefore analysed.
173 (69%) of the responding participants routinely
choose to follow-up patients with testicular microlithiasis
while 78 (31%) do not. Of those who do, 119 (69%)
decide to follow-up all patients while 54 (31%) only do
so for a selected patient group.
Of the 173 participants who do follow-up microlithiasis,
all but one consultant used ultrasonography in addition
to clinical examination as part of their surveillance. This
lone consultant uses annual clinical examination as his
preferred method of follow-up. While 10 (6%) of the par-
ticipating consultants arrange ultrasound scan on a 6
monthly basis, a vast majority of them 151 (88%) do it
annually. A further 10 (6%) scan patients at more
extended intervals.
27 (16%) consultants request tumour markers in addition
to ultrasound scan, while 10 (6%) would consider biopsy
in selected group of patients.
With regard to the duration of follow-up these patients,
66 (38%) of the positive responders would follow-up
their patients for life, while 80 (47%) would follow them
up until they were 55 yrs of age. 26 (15%) would dis-
charge their patients after 5 yrs of surveillance.
Based on their understanding of the current literature 173
(69%) participants believe testicular microlithiasis is asso-
ciated with carcinoma-in-situ in less than 1% of patients.
53 (21%) felt this figure to be between 1–10% while 7
(3%) believe it to be greater than 10%.
109 (43%) participants believe that surveillance does con-
fer a survival benefit for microlithiasis patients who go on
to develop testicular malignancy while 142 (57%) do not.
Interestingly, 66 (38%) responders who do choose to fol-
low-up this patient group do not think there is a survival
benefit.
Discussion
Microlithiasis in the testis can be histological or radiolog-
ical microcalification. They are not essentially the same
entity. Of interest to the urologist however is the radiolog-
ically detected micolithiasis.
Oiye was the first to describe intratesticular calicifications
in 6 of 192 testicles in autopsy specimens as early as1928
[14]. This report was followed a year later by Blumensaat,
who reported similar intratubular bodies in postmortem
specimens [15]. He felt they were degenerated spermato-BMC Urology 2006, 6:8 http://www.biomedcentral.com/1471-2490/6/8
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gonia displaced into the lumen of the seminiferous
tubules. Later Bigger and Mc Adams using various histo-
chemical techniques found that the laminated eosi-
nophilic material was a glycoprotein derived from intra
tubular secretions, which later calcified [16]. But it was
not until 1961 that Azzopardi & Mostofi [17] from the
Armed forces institute of Pathology in Washington
described the two different types of intra-testicular calcifi-
cation and their associated pathology. They reported the
more commonly found rounded laminated intra tubular
calicifications associated with cryptorchid testis, adenom-
atous or inflammatory pathology. They then reported the
amorphous haematoxylin staining calcific bodies in
dilated seminiferous tubules found in 13 of 17 patients
with wide spread chorio-carcinoma. Histo-chemical
methods showed them to consist of phospholipid, pro-
tein debris, DNA and calcium phosphate. These calcifica-
tions were seen in close association with malignant
neoplastic cells.
Diffuse microcalcification in the testis on a plain X ray
film was first reported by Priebe & Garret in a 4 year old
boy with an otherwise normal testicle in 1970 [18]. But it
was not until the mid 80 s when Doherty et al using a 10-
MHz transducer first described ultra sonically detected tes-
ticular microlithiasis [1]. Ever since, the interest in this
entity has increased, with several case reports and retro-
spective studies reporting an association with testicular
cancer [2-8]. However these studies were either isolated
case reports or retrospective studies in selected group of
patients.
In one series of 263 sub-fertile men, 20% were found to
have microlithiasis [12]. In the same study 20% of the
men with bilateral microlithiasis were found to have CIS.
Interestingly there was no association of CIS with unilat-
eral microlithiasis in this study group. In another series of
patients with testicular germ cell tumour Skakkabaek
found a significant association of contra-lateral testicular
microlithiasis and CIS [13]. Clearly in the high-risk group
(described earlier) there seems be a significant association
of testicular microlithiasis and CIS, which needs to be
clarified with further longitudinal studies.
In an ultrasound screening study involving 1504 men
between 18 to 35 years from the US army officer corps,
Peterson & Costabile R A. [9] found the prevalence of tes-
ticular microlithiasis to be 5.6%. In this study African
Americans were found to have a higher prevalence of 14%
as opposed to whites who had a prevalence of 4%. How-
ever the incidence of testicular tumour is higher in whites
than African Americans. Analysis of the geographical dis-
tribution of these cases showed a negative correlation
with the incidence of testicular tumour in the United
States. Interestingly there was an association with STD in
the regions where testicular microlithiasis had a higher
prevalence in this study. In their follow-up report after
more than 4 years presented at the AUA meeting in 2004
at San Francisco, USA, they have not had a single case of
testicular tumour in their study subjects with testicular
microlithiasis.
Our survey confirms that many urologists tend to follow
this patient group for a considerable period of time. How-
ever there seems to be a considerable variation in the sur-
veillance policy. This is likely to have an enormous
bearing on the cost conscious NHS practice in future. The
estimated cost in the United States to follow-up all
patients with microlithiasis between 18-to 35 years old
are about 18-billion dollars per year [10]. It is also known
from many studies that there is an average delay of 3–6
months between noticing a testicular lump and seeking
medical advice without significantly affecting cure. With
the cure rate for testicular cancer exceeding 90%, it is
debatable whether an earlier ultrasound diagnosis will
have any effect on the outcome than self examination.
With the emerging evidence it seems safe not to routinely
follow-up patients who are incidentally diagnosed with
testicular microilithiasis [9-11]. They should however be
advised to continue testicular self-examination. The
importance of testicular microlithiasis in the high-risk
groups is not clear and needs further evidence. Until such
time it would be logical to follow-up all patients in the
high risk group.
We do acknowledge that the response rate to our ques-
tionnaire survey has been moderate, with only 57%
returns. This has a small chance of bias towards urologists
actively following microlithiasis returning the question-
naire, than those who are not keen on following them.
However this is more likely to be due to the fact that the
questionnaire was sent during school term holidays,
when many urologists tend to be on annual leave. The
returns were also fairly evenly distributed throughout the
UK.
Conclusion
Our survey highlights a significant variation in how
patients with testicular microlithiasis are followed-up in
the UK. The majority of consultants nationally believe sur-
veillance of this patient group confers no survival benefit.
However significant proportions of them continue to fol-
low-up these patients. There is an urgent need to clarify
this issue in order to recommend a coherent surveillance
policy.
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